A real world study assessing the characteristics of Ankylosing Spondylitis patients who initiated Secukinumab in Portugal
Latest Information Update: 20 Nov 2020
At a glance
- Drugs Secukinumab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 20 Nov 2020 New trial record
- 19 Nov 2020 Results presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research